DrugDashboards

Dapsone

Dapsone Gel, 5% · DAPSONE 50 mg/g · Gel · Topical · Trupharma, LLC

NDC 52817-0831-90 · 1 TUBE in 1 CARTON / 90 g in 1 TUBE · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price has fallen 45% in a year, to $0.6700 per gram — and generics that get this cheap tend to get abandoned rather than defended. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$1.00$2.00Apr 2025Sep 2026$0.67
17 price points · per GMSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$108.00
Reported to Texas DSHS · 2026 annual filing · TruPharma, LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$20,351
182 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

35Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 2 active manufacturers+20
  • price down 44% year over year+15

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for dapsone (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA213907
TE code
AB
Approval date
Jun 6, 2023
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Dapsone Gel, 5% (Gel)

LabelerStrengthFirst seenLast seen
Encube Ethicals, Inc.DAPSONE 50 mg/gJul 15, 2026Sep 2, 2026
Trupharma, LLCDAPSONE 50 mg/gJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Dapsone — NDC 52817-0831-90," retrieved September 3, 2026, https://drugdashboards.com/drug/52817083190.

Free to cite with attribution — see how the data is put together.